Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

SNA 11

Next Previous
X
Search
Drug Profile

SNA 11

Alternative Names: SNA-11; Synxyrin®

Latest Information Update: 15 Oct 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SyneuRx International (Taiwan) corp
  • Class Antidepressants
  • Mechanism of Action NMDA receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Major depressive disorder

Most Recent Events

  • 15 Oct 2024 Phase-I development for Major depressive disorder is ongoing in Taiwan (Syneurx International pipeline, October 2024)
  • 28 May 2024 No recent reports of development identified for phase-I development in Major depressive disorder(Treatment-resistant) in Taiwan
  • 23 Sep 2022 SyneuRX plans a phase-II trial in Major depressive disorder in USA (SyneuRX pipeline, September 2022).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top